Do we need more iron-chelating drugs?
Kontoghiorghes
George J
GJ
D001565:Benzoates / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D000077588:Deferasirox; D000077543:Deferiprone; D003676:Deferoxamine / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007502:Iron Chelating Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000378:metabolism; D011728:Pyridones / Q000493:pharmacokinetics / Q000627:therapeutic use; D013789:Thalassemia / Q000188:drug therapy / Q000378:metabolism; D014230:Triazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D001565:Benzoates; D007502:Iron Chelating Agents; D011728:Pyridones; D014230:Triazoles; D000077543:Deferiprone; D003676:Deferoxamine; D000077588:Deferasirox